Yuichi Ando

19PUBLICATIONS
69CO-AUTHORS
Haematological tumoursPredictive and prognostic markersPharmacogenomicsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (19)

|Sep 11, 2026
Impact of Dyslipidemia on Clinical Outcomes Among Cancer Patients Treated With Immune Checkpoint Inhibitors.

|Jul 15, 2026
Comprehensive genomic profiling and tumor mutational burden in parathyroid carcinoma: a nationwide real-world study from Japan.

|Jul 02, 2025
Pazopanib and antacids: insights from the WHO pharmacovigilance database.

Kazuki Nishida, Yao Liang, Osamu Maeda

|Jun 14, 2025
Safety and efficacy of retreatment with immune checkpoint inhibitors after severe immune-related adverse events.

Kazuyuki Mizuno, Takanori Ito, Tsunaki Sawada

|Jan 31, 2025
Genomic profiles of patients with skin melanoma in the era of immune checkpoint inhibitors.

Yao Liang, Osamu Maeda, Kazuki Nishida

|Jul 22, 2024
Effects of KRAS, STK11, KEAP1, and TP53 mutations on the clinical outcomes of immune checkpoint inhibitors among patients with lung adenocarcinoma.

Yao Liang, Osamu Maeda, Chiaki Kondo

Pageof 4

Frequent Collaborators

5 joint publications

Osamu Maeda

5 joint publications

Yao Liang

3 joint publications

Kazuki Nishida

2 joint publications

Basile Chrétien